Afya is trading at $13.50, up 10.47%, with its proposed YDUQS merger the clearest catalyst.
- Under the proposal, Afya would merge into YDUQS, with shareholders receiving YDUQS shares; the surviving company would remain listed on Brazilβs B3, and Afya would cease to exist separately.
- Announced September 23, the deal remains subject to approvals; an October 1 voting-commitment release described an ongoing process, not an October 5 completion.
- Broad market cues were mixed and modest, offering less explanation than the company-specific merger news.